340B Drug Allocation Provision In Tax Bill Needs Clarification, Attorney Says
A provision in a tax bill passed by the House May 28 would require manufacturers facing a shortage of an inpatient drug used by 340B program hospitals to submit a drug allocation plan to HHS for approval
You may also be interested in...
Dropped from health reform, a proposal to extend 340B discounts to inpatient drugs is included in "The American Jobs and Closing Tax Loopholes Act," sponsored by Senate and House committee chairmen.
A long-promised official policy on "penny pricing" for drugs sold to 340B entities is on hold until Congress appropriates funding for the Health Resources and Services Administration's Office of Pharmacy Affairs. Until then, drug manufacturers will need to work on a case-by-case basis with OPA to resolve any pricing issues
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011